Even if
@narf 's projection currently looks a tad optimistic
Yeah, I see multiple deviations from the plan:
- AZ underdelivering (as usual, none of the weekly numbers projected matches reality, both up and down but more down than up)
- JJ underdelivering (those millions of doses)
- Moderna underdelivering (KW23 shipment is missing)
- we're apparently either more careful wrt keeping buffers, or there's some bottleneck somewhere, or some reporting delays. Here's the total stock for every day so far:
Keeping more stock in absolute numbers when the rate of doses per week is higher makes sense, the bumps in stock during February and since Easter correlate with significant speedups in the campaign. However, the bump up in June doesn't really match up with a significant speedup... so maybe the powers that be took the increasing unreliability of all suppliers, now including even Biontech, as a reason to keep a bit more in stock to ensure no hiccups in the chain.
Also, July numbers are out - July is going to suck, relatively speaking. We're dropping back to 3M Bnt a week, and Moderna isn't picking up the slack yet. AZ & JJ are virtually irrelevant.
More positive news, the first shot fraction is going to go up again soon because the rise in 2nd shots is about five weeks ago.
Also positive news: 10 out of 14 reporting Länder have crossed over 80% first shot rate in the 60+ population, all 14 are above 50% fully vax'd. The effect of this is visible in the data too, the older population has had a significantly lower rate of new cases for months now.
Additionally, covid deaths from wave 3 are now reasonably visible, and muuuuuch lower than during wave 2. What changed? Group 1 vaccination.
Even more positive news: The RKI has done some statistical magic today based on cases of vaccinated people getting symptomatic covid, and estimate 97-98.7% real-world vaccination effectiveness against symptomatic covid.